Introduction:
Sleep diagnostics specialist Onera Health NV has raised €30m (US$32m) in a Series C financing round. The round was co-led by EQT Life Sciences and Gimv, with participation from existing investors Innovation Industries, Invest-NL, imec.xpand, BOM, and 15th Rock.
- Onera Health has raised €30m (US$32m) in a Series C financing round.
- The funding round was co-led by EQT Life Sciences and Gimv, with participation from existing investors.
- Onera Health plans to use the funding to accelerate manufacturing and deployment of its sleep diagnostics and monitoring device.
- The company also aims to expedite the clearance of the second generation of its polysomnography (PSG) system in Europe and the United States.
- Drew Burdon and Michaël Vlemmix will join Onera Health’s Board of Directors as part of the financing.
Conclusion:
Onera Health has secured €30m (US$32m) in funding to support the manufacturing and deployment of its sleep diagnostics and monitoring device. This financing will also help the company accelerate the clearance process for its second-generation polysomnography system. The participation of EQT Life Sciences and Gimv, as well as the addition of new members to the Board of Directors, highlight the confidence in Onera Health’s technology and its potential for growth in the sleep diagnostics market.
